Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis

Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to...

Full description

Bibliographic Details
Main Authors: Taha Gholipour, Taher Ghazizadeh, Sahand Babapour, Behzad Mansouri, Majid Ghafarpour, Bahaadin Siroos, Mohammad Hossein Harirchian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2015-02-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407
id doaj-ca6ee521942b45e2a1667505834fff86
record_format Article
spelling doaj-ca6ee521942b45e2a1667505834fff862020-11-25T04:12:27ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492015-02-01141372Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple SclerosisTaha Gholipour0Taher Ghazizadeh1Sahand Babapour2Behzad Mansouri3Majid Ghafarpour4Bahaadin Siroos5Mohammad Hossein Harirchian6Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranIranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranIranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranSection of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran. Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to measure the urine level of one of melatonin products which is an index of serum melatonin level, in MS patients in the acute phase of relapse and control patients. We also analyzed different clinical and cognitive indices in order to find any correlation with melatonin level. Twenty eight patients who were diagnosed as relapsing-remitting MS, according to the revised McDonald criteria, along with 10 age- and sex-matched control subjects were recruited in our study. Here we showed that urine 6-sulphatoxymelatonin levels (aMT6s; the major metabolite of melatonin) were significantly lower in MS patients compared to control group. Interestingly, urine aMT6s levels significantly correlated with MS Functional Composite score, but not Expanded Disability Severity Score. Based on above findings, there might be new hope in developing a quantitative and objective measure to assess the MS severity especially in neurodegenerative diseases. However, our results should be analyzed cautiously. We didn't evaluate simultaneous level of 25-OH Vitamin D. It has been recently reported that there is a negative correlation between melatonin and vitamin D levels. Further studies are needed to confirm this hypothesis.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407Cognitive FunctionMelatoninMultiple Sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author Taha Gholipour
Taher Ghazizadeh
Sahand Babapour
Behzad Mansouri
Majid Ghafarpour
Bahaadin Siroos
Mohammad Hossein Harirchian
spellingShingle Taha Gholipour
Taher Ghazizadeh
Sahand Babapour
Behzad Mansouri
Majid Ghafarpour
Bahaadin Siroos
Mohammad Hossein Harirchian
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
Iranian Journal of Allergy, Asthma and Immunology
Cognitive Function
Melatonin
Multiple Sclerosis
author_facet Taha Gholipour
Taher Ghazizadeh
Sahand Babapour
Behzad Mansouri
Majid Ghafarpour
Bahaadin Siroos
Mohammad Hossein Harirchian
author_sort Taha Gholipour
title Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
title_short Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
title_full Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
title_fullStr Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
title_full_unstemmed Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
title_sort decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis
publisher Tehran University of Medical Sciences
series Iranian Journal of Allergy, Asthma and Immunology
issn 1735-1502
1735-5249
publishDate 2015-02-01
description Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to measure the urine level of one of melatonin products which is an index of serum melatonin level, in MS patients in the acute phase of relapse and control patients. We also analyzed different clinical and cognitive indices in order to find any correlation with melatonin level. Twenty eight patients who were diagnosed as relapsing-remitting MS, according to the revised McDonald criteria, along with 10 age- and sex-matched control subjects were recruited in our study. Here we showed that urine 6-sulphatoxymelatonin levels (aMT6s; the major metabolite of melatonin) were significantly lower in MS patients compared to control group. Interestingly, urine aMT6s levels significantly correlated with MS Functional Composite score, but not Expanded Disability Severity Score. Based on above findings, there might be new hope in developing a quantitative and objective measure to assess the MS severity especially in neurodegenerative diseases. However, our results should be analyzed cautiously. We didn't evaluate simultaneous level of 25-OH Vitamin D. It has been recently reported that there is a negative correlation between melatonin and vitamin D levels. Further studies are needed to confirm this hypothesis.
topic Cognitive Function
Melatonin
Multiple Sclerosis
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407
work_keys_str_mv AT tahagholipour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT taherghazizadeh decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT sahandbabapour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT behzadmansouri decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT majidghafarpour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT bahaadinsiroos decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
AT mohammadhosseinharirchian decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis
_version_ 1724415414883057664